3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
1
Conditions
Neoplasms
11
Prostatic Neoplasms
10
Breast Neoplasms
8
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lung Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Renal Cell
3
Thrombocythemia, Essential
2
Testicular Neoplasms
2
Stomach Neoplasms
2
Skin Diseases
2
Primary Myelofibrosis
2
Polycythemia Vera
2
Myeloproliferative Disorders
2
Melanoma
2
Lymphoma, Large B-Cell, Diffuse
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Myeloid, Acute
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia
2
Hodgkin Disease
2
Hematologic Diseases
2
Glioma
2
Burkitt Lymphoma
2
Breast Neoplasms, Male
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Interventions
Watchful Waiting
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Hemangioma, Cavernous
×
Watchful Waiting
×
Clear all
NCT04467489
2025-08-11
Biomarkers of CASH
University of Chicago
Active not recruiting
1,040 enrolled